These results correspond to those of McCoy et al. [57] who showed that the loss of viability by GX15-070 treatment was not prevented in BAK/BAX knockout mouse embryonic fibroblasts and also to the data of Brem et al. [58] who reported on cell death induction by GX15-070 in lymphoma cells regardless of baseline BAK and BAX levels. This evidence concerns the gene BAX and lymphoma.